Valuation: Aprogen Biologics Inc.

Market Cap 45.2B 32.61M 27.93M 26.14M 23.93M 44.9M 3.12B 45.5M 309M 120M 1.57B 122M 120M 5.18B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 222B 160M 137M 129M 118M 221M 15.35B 224M 1.52B 592M 7.71B 602M 589M 25.51B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
47.93%
Yield 2024 *
-
Yield 2025 -
1 day-2.98%
1 week-6.57%
Current month-9.43%
1 month-3.03%
3 months-44.35%
6 months-66.32%
Current year-75.34%
1 week 1,874
Extreme 1874
2,025
1 month 1,874
Extreme 1874
2,350
Current year 1,869
Extreme 1869
8,490
1 year 1,869
Extreme 1869
10,395
3 years 1,869
Extreme 1869
83,850
5 years 1,869
Extreme 1869
204,750
10 years 1,869
Extreme 1869
858,000
Manager TitleAgeSince
Chief Executive Officer 63 2023-10-12
Chief Executive Officer 70 2012-03-31
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 2012-03-31
Director/Board Member 65 2020-03-22
Director/Board Member 63 2023-10-12
Date Insider Type Main position Quantity % Market Cap.
6/28/24 Fiscal year

Executive/Senior Manager

6,183 0.0046%
6/28/24 Expiration

Chief Executive Officer

21,884 0.0164%
6/28/24 Fiscal year 11,846 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-2.98%-6.57%-79.29%-97.56% 32.61M
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +0.86%+3.82%+20.41%+38.34% 379.99B
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2024 2025
Net sales 67.38B 48.62M 41.65M 38.97M 35.67M 66.94M 4.65B 67.83M 460M 180M 2.34B 183M 179M 7.73B 73.23B 52.84M 45.26M 42.35M 38.77M 72.75M 5.06B 73.71M 500M 195M 2.54B 198M 194M 8.4B
Net income -105B -75.75M -64.89M -60.71M -55.58M -104M -7.25B -106M -717M -280M -3.64B -284M -278M -12.04B -170B -123M -105M -98.51M -90.17M -169M -11.76B -171M -1.16B -454M -5.91B -461M -451M -19.54B
Net Debt 116B 83.48M 71.51M 66.91M 61.25M 115M 7.99B 116M 791M 308M 4.01B 313M 307M 13.27B 177B 128M 110M 102M 93.79M 176M 12.23B 178M 1.21B 472M 6.14B 480M 470M 20.32B
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
379
Date Price Change Volume
26-08-21 ₩1,920.00 -2.98% 61,329
26-08-20 ₩1,979.00 +3.83% 56,205
26-08-19 ₩1,906.00 -2.16% 65,097
26-08-18 ₩1,948.00 -5.21% 124,952
26-08-14 ₩2,055.00 0.00% 64,165
  1. Stock Market
  2. Stocks
  3. A003060 Stock